Solivio, Vanesa C.
HRN: 18-52-25 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2022
CEFUROXIME 500MG (TAB)
07/18/2022
07/25/2022
PO
500mg
Q12
S/P NSD UTI
Waiting Final Action